Elevated PSA lacks both sensitivity and specificity for the diagnosis of clinically significant prostate cancer: while a significant proportion of patients with an elevated PSA, regardless of definition, will not have prostate cancer, up to 25% of men aged 50 to 70 years old with a normal PSA would be expected to have high grade prostate cancer6. This evidence concerns the gene KLK3 and prostate carcinoma.